XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 12,079 $ 83,216,387 $ (2,157,225) $ (87,388,619) $ (6,317,378)
Beginning balance, shares at Dec. 31, 2019 12,079,095          
Stock-based compensation 1,462,270 1,462,270
Restricted common stock grant $ 846 (846)
Restricted common stock grant, shares 846,591          
Restricted common stock forfeitures $ (37) 37
Restricted common stock forfeitures, shares (36,750)          
Issuance of common stock upon conversion of secured convertible notes and interest $ 2,625 3,022,060 3,024,685
Issuance of common stock upon conversion of secured convertible notes and interest, shares 2,624,212          
Issuance of common stock through underwritten public offering at $1.15 per share (net of offering expenses and underwriters’ discount) $ 2,522 2,499,614 2,502,136
Issuance of common stock through underwritten public offering at $1.15 per share (net of offering expenses and underwriters' discount), shares 2,521,740          
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount) $ 3,554 5,346,859 5,350,413
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount), shares 3,554,545          
Issuance of common stock through underwritten public offering at $2.15 per share (net of offering expenses and underwriters’ discount) $ 2,540 4,974,152 4,976,692
Issuance of common stock through underwritten public offering at $2.15 per share (net of offering expenses and underwriters' discount), shares 2,539,534          
Issuance of common stock upon exercise of common stock purchase warrants $ 2,694 5,200,428 5,203,122
Issuance of common stock upon exercise of common stock purchase warrants, shares 2,693,867          
Issuance of common stock purchase warrants in connection with issuance of secured convertible notes 721,141 721,141
Issuance of common stock upon exercise of stock options $ 2 7,798 7,800
Issuance of common stock upon exercise of stock options, shares 1,875          
Issuance of common stock for services rendered $ 10 30,690 30,700
Issuance of common stock for services rendered, shares 10,000          
Issuance of common stock purchase warrants in connection with issuance of unsecured promissory note payable 20,806 20,806
Net income (loss) (2,625,881) (2,625,881)
Ending balance, value at Dec. 31, 2020 $ 26,835 106,501,396 (2,157,225) (90,014,500) 14,356,506
Ending balance, shares at Dec. 31, 2020 26,834,709          
Stock-based compensation 1,605,949 1,605,949
Restricted common stock grant $ 856 (856)
Restricted common stock grant, shares 856,000          
Restricted common stock forfeitures $ (8) 8
Restricted common stock forfeitures, shares (7,700)          
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount) $ 3,250 6,614,350 6,617,600
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount), shares 3,250,000          
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount) $ 2,800 6,726,200 6,729,000
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount), shares 2,800,000          
Exercise of pre-funded common stock purchase warrants at $3.095 per share $ 7,200 22,276,800 22,284,000
Exercise of pre-funded common stock purchase warrants at $3.095 per share, shares 7,200,000          
Exercise of pre-funded common stock purchase warrants at $2.80 per share $ 11,050 30,928,950 30,940,000
Exercise of pre-funded common stock purchase warrants at $2.80 per share, shares 11,050,000          
Issuance of pre-funded common stock purchase warrants in connection with the registered direct offerings (1,817,548) (1,817,548)
Issuance of common stock purchase warrants at exercise price of $3.25 per share in connection with the registered direct offerings (49,398,510) (49,398,510)
Issuance of common stock as consideration for acquisition $ 720 989,640 990,360
Issuance of common stock as consideration for acquisition, shares 719,738          
Repurchase and cancellation of common stock $ (1,735) (1,973,344) (1,975,079)
Repurchase and cancellation of common stock, shares (1,734,838)          
Cancellation of treasury stock $ (64) 2,157,225 (2,157,161)
Cancellation of treasury stock, shares (63,518)          
Net income (loss) 56,453 25,474,508 25,530,961
Ending balance, value at Dec. 31, 2021 $ 50,904 $ 124,426,379 $ 56,453 $ (68,670,497) $ 55,863,239
Ending balance, shares at Dec. 31, 2021 50,904,391